Market Cap 4.48B
Revenue (ttm) 0.00
Net Income (ttm) -183.79M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.15
Volume 12,213,400
Avg Vol 2,975,580
Day's Range N/A - N/A
Shares Out 99.70M
Stochastic %K 91%
Beta 2.37
Analysts Strong Sell
Price Target $56.00

Company Profile

Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders. The company's lead product candidates DT120, which is in phase 3 for the treatment of generalized anxiety disorder, major depressive disorder, and other brain health disorders; and DT402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase 2a clinical trials for the treatment of autism spectrum disorder. The company was formerly known as Mind Me...

Industry: Biotechnology
Sector: Healthcare
Phone: 212 220 6633
Address:
One World Trade Center, Suite 8500, New York, United States
VisionAlpha
VisionAlpha Jun. 29 at 1:02 PM
Don't fall for the social media spam. The $DFTX tape is completely dead at $44.84 on next to zero volume. Institutions aren't here. Not chasing.
1 · Reply
FutureBulls
FutureBulls Jun. 29 at 1:00 PM
While promotional WhatsApp groups spam links to target retail chasers, the $DFTX tape tells a colder story. It's flatlining at $44.84 on nonexistent volume. The tape has to prove it.
0 · Reply
JuggernautRaider
JuggernautRaider Jun. 29 at 7:29 AM
$DFTX very intriguing 🤔 https://www.fiercebiotech.com/biotech/definiums-lsd-formula-produces-best-data-ever-seen-pivotal-depression-trial-ceo-says
0 · Reply
twiggs462
twiggs462 Jun. 29 at 1:27 AM
$CMPS $DFTX $ATAI Great PBS video... https://youtu.be/g9z1bqK1sco?is=4108rA4Krw_IiD9u
0 · Reply
MoonReaper
MoonReaper Jun. 28 at 11:25 PM
Why $DFTX Just Exploded 30%
0 · Reply
Rocketzz
Rocketzz Jun. 28 at 6:54 PM
$DFTX Q3 squeeze is going to be epic
1 · Reply
MichaelNaussCMT
MichaelNaussCMT Jun. 28 at 6:13 PM
$DFTX didn’t think so
1 · Reply
Canadian10
Canadian10 Jun. 28 at 5:49 PM
0 · Reply
EventHorizon8
EventHorizon8 Jun. 28 at 1:33 AM
Helus is set to follow the path of Definium but imagine another possibility. What if Helus and Definium merge and take on big pharma directly with two best in their class treatments for depression combined with Helus’s duteration tech. It would be lethal to big pharma and create a money printing press for investors. Think about it . $DFTX $HELP
1 · Reply
twiggs462
twiggs462 Jun. 27 at 11:26 PM
$DFTX Definium After Emerge: Phase 3 Validation, Big Pharma Interest, and the Next Wave in Psychedelic Psychiatry https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177740379
1 · Reply
Latest News on DFTX
Biotech ETF Index Surges 10% After Rebalance

Jun 25, 2026, 11:31 AM EDT - 3 days ago

Biotech ETF Index Surges 10% After Rebalance

ALKS APGE DYN KLRA KYMR MANE MIRM


Definium Therapeutics rises 21.8%

2026-06-24T16:05:36.000Z - 4 days ago

Definium Therapeutics rises 21.8%


Definium Therapeutics rises 17.7%

2026-06-24T14:05:51.000Z - 4 days ago

Definium Therapeutics rises 17.7%


Definium Therapeutics 20.6M share Secondary priced at $34.00

2026-06-24T10:20:19.000Z - 5 days ago

Definium Therapeutics 20.6M share Secondary priced at $34.00


Definium Therapeutics offers to sell $500M in common stock

2026-06-22T20:18:37.000Z - 6 days ago

Definium Therapeutics offers to sell $500M in common stock


Definium Therapeutics rises 55.9%

2026-06-22T16:11:28.000Z - 6 days ago

Definium Therapeutics rises 55.9%


Definium Therapeutics rises 55.7%

2026-06-22T14:12:05.000Z - 6 days ago

Definium Therapeutics rises 55.7%


Definium Therapeutics Transcript: Study result

Jun 22, 2026, 8:00 AM EDT - 7 days ago

Definium Therapeutics Transcript: Study result


Definium Therapeutics Press release: Study result

Jun 22, 2026, 8:00 AM EDT - 7 days ago

Definium Therapeutics Press release: Study result


Definium Therapeutics Slides: Study result

Jun 22, 2026, 8:00 AM EDT - 7 days ago

Definium Therapeutics Slides: Study result


Definium Therapeutics Slides: Corporate presentation

Jun 22, 2026, 7:00 AM EDT - 7 days ago

Definium Therapeutics Slides: Corporate presentation


Definium Therapeutics Announces New Employee Inducement Grants

Jun 15, 2026, 4:01 PM EDT - 13 days ago

Definium Therapeutics Announces New Employee Inducement Grants


Definium Therapeutics Transcript: AGM 2026

Jun 11, 2026, 10:00 AM EDT - 17 days ago

Definium Therapeutics Transcript: AGM 2026


Definium Therapeutics Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 7 weeks ago

Definium Therapeutics Earnings Call Transcript: Q1 2026


Definium Therapeutics Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 7 weeks ago

Definium Therapeutics Earnings release: Q1 2026


Definium Therapeutics Quarterly report: Q1 2026

May 7, 2026, 4:30 PM EDT - 7 weeks ago

Definium Therapeutics Quarterly report: Q1 2026


Definium Therapeutics Slides: Corporate presentation

May 7, 2026, 4:00 PM EDT - 7 weeks ago

Definium Therapeutics Slides: Corporate presentation


Definium Therapeutics Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 2 months ago

Definium Therapeutics Proxy statement: Proxy filing


Definium Therapeutics Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 2 months ago

Definium Therapeutics Proxy statement: Proxy filing


Definium Therapeutics Transcript: Investor Day 2026

Apr 22, 2026, 10:00 AM EDT - 2 months ago

Definium Therapeutics Transcript: Investor Day 2026


Definium Therapeutics Slides: FY 2026

Apr 22, 2026, 10:00 AM EDT - 2 months ago

Definium Therapeutics Slides: FY 2026


Psychedelic stocks rally with Trump's support

Apr 20, 2026, 8:26 AM EDT - 2 months ago

Psychedelic stocks rally with Trump's support

ATAI CMPS GHRS


Definium Therapeutics Transcript: Stifel 2026 Virtual CNS Forum

Mar 17, 2026, 3:30 PM EDT - 3 months ago

Definium Therapeutics Transcript: Stifel 2026 Virtual CNS Forum


Definium Therapeutics Earnings Call Transcript: Q4 2025

Feb 26, 2026, 4:30 PM EST - 4 months ago

Definium Therapeutics Earnings Call Transcript: Q4 2025


Definium Therapeutics Annual report: Q4 2025

Feb 26, 2026, 4:30 PM EST - 4 months ago

Definium Therapeutics Annual report: Q4 2025


Definium Therapeutics Earnings release: Q4 2025

Feb 26, 2026, 4:30 PM EST - 4 months ago

Definium Therapeutics Earnings release: Q4 2025


Definium Therapeutics Slides: Corporate presentation

Feb 26, 2026, 4:00 PM EST - 4 months ago

Definium Therapeutics Slides: Corporate presentation


Definium Therapeutics Slides: Corporate presentation

Jan 12, 2026, 2:45 PM EST - 5 months ago

Definium Therapeutics Slides: Corporate presentation


MindMed Announces New Employee Inducement Grant

Dec 15, 2025, 4:01 PM EST - 6 months ago

MindMed Announces New Employee Inducement Grant


MindMed Announces New Employee Inducement Grants

Dec 1, 2025, 4:01 PM EST - 7 months ago

MindMed Announces New Employee Inducement Grants


Definium Therapeutics Slides: Corporate Presentation

Nov 9, 2025, 6:00 PM EST - 8 months ago

Definium Therapeutics Slides: Corporate Presentation


Definium Therapeutics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 8 months ago

Definium Therapeutics Earnings Call Transcript: Q3 2025


Definium Therapeutics Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 8 months ago

Definium Therapeutics Quarterly report: Q3 2025


Definium Therapeutics Earnings release: Q3 2025

Nov 6, 2025, 4:30 PM EST - 8 months ago

Definium Therapeutics Earnings release: Q3 2025


MindMed Reports Q3 2025 Financial Results and Business Updates

Nov 6, 2025, 4:01 PM EST - 8 months ago

MindMed Reports Q3 2025 Financial Results and Business Updates


Definium Therapeutics Slides: Corporate Presentation

Nov 6, 2025, 7:00 AM EST - 8 months ago

Definium Therapeutics Slides: Corporate Presentation


MindMed to Participate in Upcoming Investor Conferences

Nov 5, 2025, 7:01 AM EST - 8 months ago

MindMed to Participate in Upcoming Investor Conferences


MindMed to Report Q3 2025 Financial Results on November 6, 2025

Oct 30, 2025, 4:01 PM EDT - 8 months ago

MindMed to Report Q3 2025 Financial Results on November 6, 2025


Mind Medicine (MindMed) Inc. Announces Proposed Public Offering

Oct 29, 2025, 4:01 PM EDT - 8 months ago

Mind Medicine (MindMed) Inc. Announces Proposed Public Offering


MindMed to Participate in September Investor Conferences

Aug 28, 2025, 7:00 AM EDT - 10 months ago

MindMed to Participate in September Investor Conferences


Definium Therapeutics Earnings Call Transcript: Q2 2025

Jul 31, 2025, 4:30 PM EDT - 11 months ago

Definium Therapeutics Earnings Call Transcript: Q2 2025


Definium Therapeutics Quarterly report: Q2 2025

Jul 31, 2025, 4:30 PM EDT - 11 months ago

Definium Therapeutics Quarterly report: Q2 2025


Definium Therapeutics Earnings release: Q2 2025

Jul 31, 2025, 4:30 PM EDT - 11 months ago

Definium Therapeutics Earnings release: Q2 2025


Definium Therapeutics Slides: Q2 2025

Jul 31, 2025, 4:30 PM EDT - 11 months ago

Definium Therapeutics Slides: Q2 2025


MindMed Reports Q2 2025 Financial Results and Business Updates

Jul 31, 2025, 4:01 PM EDT - 11 months ago

MindMed Reports Q2 2025 Financial Results and Business Updates


Definium Therapeutics Transcript: AGM 2025

Jun 12, 2025, 10:00 AM EDT - 1 year ago

Definium Therapeutics Transcript: AGM 2025


MindMed to Participate in June Investor Conferences

May 28, 2025, 7:00 AM EDT - 1 year ago

MindMed to Participate in June Investor Conferences


Definium Therapeutics Earnings Call Transcript: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Definium Therapeutics Earnings Call Transcript: Q1 2025


Definium Therapeutics Quarterly report: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Definium Therapeutics Quarterly report: Q1 2025


Definium Therapeutics Earnings release: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Definium Therapeutics Earnings release: Q1 2025


Definium Therapeutics Slides: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Definium Therapeutics Slides: Q1 2025


Definium Therapeutics Proxy statement: Proxy Filing

Apr 23, 2025, 8:00 AM EDT - 1 year ago

Definium Therapeutics Proxy statement: Proxy Filing


Definium Therapeutics Proxy statement: Proxy Filing

Apr 23, 2025, 8:00 AM EDT - 1 year ago

Definium Therapeutics Proxy statement: Proxy Filing


MindMed Appoints Matt Wiley as Chief Commercial Officer

Mar 17, 2025, 7:00 AM EDT - 1 year ago

MindMed Appoints Matt Wiley as Chief Commercial Officer


VisionAlpha
VisionAlpha Jun. 29 at 1:02 PM
Don't fall for the social media spam. The $DFTX tape is completely dead at $44.84 on next to zero volume. Institutions aren't here. Not chasing.
1 · Reply
FutureBulls
FutureBulls Jun. 29 at 1:00 PM
While promotional WhatsApp groups spam links to target retail chasers, the $DFTX tape tells a colder story. It's flatlining at $44.84 on nonexistent volume. The tape has to prove it.
0 · Reply
JuggernautRaider
JuggernautRaider Jun. 29 at 7:29 AM
$DFTX very intriguing 🤔 https://www.fiercebiotech.com/biotech/definiums-lsd-formula-produces-best-data-ever-seen-pivotal-depression-trial-ceo-says
0 · Reply
twiggs462
twiggs462 Jun. 29 at 1:27 AM
$CMPS $DFTX $ATAI Great PBS video... https://youtu.be/g9z1bqK1sco?is=4108rA4Krw_IiD9u
0 · Reply
MoonReaper
MoonReaper Jun. 28 at 11:25 PM
Why $DFTX Just Exploded 30%
0 · Reply
Rocketzz
Rocketzz Jun. 28 at 6:54 PM
$DFTX Q3 squeeze is going to be epic
1 · Reply
MichaelNaussCMT
MichaelNaussCMT Jun. 28 at 6:13 PM
$DFTX didn’t think so
1 · Reply
Canadian10
Canadian10 Jun. 28 at 5:49 PM
0 · Reply
EventHorizon8
EventHorizon8 Jun. 28 at 1:33 AM
Helus is set to follow the path of Definium but imagine another possibility. What if Helus and Definium merge and take on big pharma directly with two best in their class treatments for depression combined with Helus’s duteration tech. It would be lethal to big pharma and create a money printing press for investors. Think about it . $DFTX $HELP
1 · Reply
twiggs462
twiggs462 Jun. 27 at 11:26 PM
$DFTX Definium After Emerge: Phase 3 Validation, Big Pharma Interest, and the Next Wave in Psychedelic Psychiatry https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177740379
1 · Reply
Solomonwisdom7
Solomonwisdom7 Jun. 27 at 8:56 PM
$CMPS $DFTX $GHRS $HELP What impact do you think the 10.3 million share shelf offering at an offering price of 4.85/share is going to have on the share price?
3 · Reply
FutureBulls
FutureBulls Jun. 27 at 7:29 PM
$DFTX isn't moving on headlines alone. The tape feels like traders are starting to position for what's ahead rather than reacting to what's already out. In biotech, the biggest moves often come from changing expectations, not perfect certainty.
0 · Reply
TRL1985
TRL1985 Jun. 27 at 5:14 PM
$DFTX I’ll be back at $28-31
3 · Reply
PacAttackInc
PacAttackInc Jun. 27 at 3:47 PM
$DFTX $800M cash and a drug ready for the FDA to approve https://www.thenew.money/article/definium-therapeutics-raises-mega-funding-round-to-advance-lsd-drug
0 · Reply
Crizzle
Crizzle Jun. 27 at 4:48 AM
$DFTX oldie but goodie
0 · Reply
RyanRabbit
RyanRabbit Jun. 27 at 3:59 AM
$DFTX What a week for DFTX longs. We were right.
0 · Reply
NasdaqFrontier
NasdaqFrontier Jun. 26 at 9:31 PM
Still holding $DFTX $VG $FOX $KLAC. The market is pricing in breakout vs rejection debate, but I think the longer-term story is still developing.
0 · Reply
Buccabrian
Buccabrian Jun. 26 at 9:03 PM
0 · Reply
MichaelNaussCMT
MichaelNaussCMT Jun. 26 at 9:00 PM
$CMPS $DFTX $GHRS $HELP low market caps and under performance happens for a reason. The market is smart.
3 · Reply
manojaggarwal
manojaggarwal Jun. 26 at 8:43 PM
$DFTX $60 next week
0 · Reply
BullsVSBearsVSYoMomma
BullsVSBearsVSYoMomma Jun. 26 at 8:30 PM
$DFTX Manipulation going on
0 · Reply
AlphaDonMega
AlphaDonMega Jun. 26 at 8:03 PM
$DFTX The rugpull with this ScamCo will be glorious..
4 · Reply